Where DNA Copying Fails Can Decide How Cancer Cells Respond to PARP Inhibitors
NYU Grossman School of Medicine researchers found that DNA-copying problems at a small set of chromosome sites can determine how cancer cells respond to PARP inhibitors, pointing to possible biomarkers of drug sensitivity.